A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants

Recruiting

Phase 3

A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants

Sponsor:

Bristol-Myers Squibb

Code:

NCT06045689

Conditions

Myelodysplastic Syndromes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Luspatercept

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information